Endoscopic therapy for Barrett's oesophagus

Gut

Volumn 54, Issue 6, 2005, Pages 875-884

  Barr, H ^a   Stone, N ^a   Rembacken, B ^b  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; OMEPRAZOLE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ARGON LASER; BARRETT ESOPHAGUS; CANCER INCIDENCE; CATHETER ABLATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DIODE LASER; DISEASE MARKER; DISEASE SEVERITY; DYSPLASIA; EARLY DIAGNOSIS; ELECTROCOAGULATION; ENDOSCOPIC SURGERY; ERADICATION THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; METAPLASIA; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; CLINICAL TRIALS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; INTESTINAL MUCOSA; RISK FACTORS; TREATMENT OUTCOME;

EID: 19644387521     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.047118     Document Type: Review

References (84)

1. Wei JT, Shaheen NJ. The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 2003;14:112-27.
2. El Serag. The epidemic of esophageal adenocarcinoma. Gastroenterol Endosc Clin N Am 2002;31:421-40.
3. Mason AC, Eloubeidi MA, el Serag. Temporal trends in survival of patients with esophageal adenocarcinoma. 1973-1997. Gastroenterology 2001;122:A30.
4. Barr H, Fitzgerald RC. Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut 2003;52:14-17.
5. Attwood SEA, Morris CD. Who defines Barrett's oesophagus: endoscopist or pathologist. Eur J Gastroenterol 2001;13:97-9.
6. Falk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
7. Shepherd NA. Dysplasia in Barrett's oesophagus. Acta Endoscopica 2000;30:123-32.
8. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000;356:2079-85.
9. Riddell RH, Goldman H, Ransohoff D. Dysplasia in inflammatory bowel disease. Standardised classification with provisional clinical application. Hum Pathol 1983;14:931-66.
10. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
11. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol, 1994;25, 1994:982-93.
12. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
13. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis or dysplasia in Barrett's oesophagus: A reaffirmation. Hum Pathol 2001;32:368-78.
14. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett's esophagus: A follow-up study based on 138 case from a diagnostic variability study. Hum Pathol 2001;32:379-88.
15. Schnell TG, Sontag SJ, Chejfec G, et al. Long term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19.
16. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51:671-6.
17. Alderson D. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works. Gut 2002;51:620-1.
18. Zaninotto G, Parenti AR, Ruol A, et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000;87:1102-5.
19. Kara MA, Bergman JGHM, Tytgat GNJ. Follow-up for high-grade dysplasia in Barrett's oesophagus. Gastrointest Endoscopy Clin N Am 2003;13:513-33.
20. Cossentino MJ, Wong RKH. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 2003;14:128-35.
21. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-9.
22. O'Sullivan GC, Sheehan D, Clarke Q, et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999;116:543-8.
23. Yusoff IF, Sahai AV. Staging esophageal adenocarcinoma. Semin Gastrointest Dis 2003;14:146-54.
24. Holscher AH, Bollschweiler E, Schneider PM, et al. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 1997;84:1470-3.
25. May A, Gunter E, Rath F, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004;53:634-40.
26. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7.
27. Ackroyd R, Brown NJ, Stephenson TJ, et al. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed. J Clin Pathol 1999;52:509-12.
28. Bamford K, James J, Barr H, et al. Electromagnetic simulation of laser-induced fluorescence in bronchial tissue and predicted optical scattering behaviour. Opt Imaging Tech Biomonitoring IV 1998;3567:18-28.
29. Johnston MH. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am 2003;13:491-504.
30. Sampliner RE. Multipolar electrocoagulation. Gastrointest Endosc Clin N Am 2003;13:449-55.
31. Barham CP, Shepherd N, Barr H. Regression of Barrett's epithelium using argon gas coagulation and acid suppression. Gut 1996;39:114.
32. Franchimont D, Van Laethem J-L, Deviere J. Argon plasma coagulation in Barrett's oesophagus. Gastrointest Endosc Clin N Am 2003;13:457-66.
33. Deviere J. Argon plasma coagulation therapy for ablation of Barrett's oesophagus. Gut 2002;51:763-4.
34. Morris CD, Byrne JP, Armstrong GRA, et al. Prevention of neoplastic progression of Barrett's oesophagus by endoscope argon beam plasma ablation. Br J Surg 2001;88:1357-62.
35. Dix AJ, Barr H. Photothermal ablation of metaplastic columnar-lined (Barrett's) oesophagus, experimental studies for safe endoscopic laser therapy. Prog Biomed Optics 1996;2922:275-80.
36. Barr H. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointest Endosc Clin N Am 2000;10:421-38.
37. Barr H, Shepherd NA, Dix A, et al. Eradication of high grade dysplasia in columnar-lined (Barrett's) oesophagus using photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
38. Heier SK, Rothman KA, Heier LM, et al. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and a randomized comparison with Nd:YAG laser therapy. Gastroenterology 1995;109:63-72.
39. Barr H, Krasner N, Boulos PB, et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990;77:93-6.
40. Gossner L, May A, Stolte M, et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999;49:8-12.
41. Tan WC, Fulljames C, Stone N, et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. J Photochem Photobiol B Biology 1999;53:75-80.
42. Li H, Walsh TN, O'Dowd G, et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental. Barretts Esophagus Surg 1994;115:176-81.
43. Coad RA, Warner PJ, Barr H, et al. On the genesis of Barrett's oesophagus: A three dimensional study of the relationship between oesophageal gland ducts, Barrett's oesophagus and associated squamous islands. Br J Cancer 2004;91:P105.
44. Van den Boogert J, Van Hillegersberg R, De Bruin RWF, et al. A rat model for Barrett's oesophagus and prospects for photodynamic therapy. Eur J Gastroenterol Hepatol 1997;9:A53.
45. Sarosi G, Brown G, Jaiswal K, et al. Reflux-damaged esophageal epithelium is replaced by cells derived from bone marrow in a rat model of Barrett's esophagus. Gastroenterology 2004;126:A49.
46. Basu KK, Pick B, Bale R, et al. Efficacy and one year follow-up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002;51:776-80.
47. Morris CD, Byrne JP, Armstrong GRA, et al. Prevention of neoplastic progression of Barrett's oesophagus by argon beam plasma ablation. Br J Surg 2001;88:1357-62.
48. Van Leathem JL, Jagodzinski R, Peny MO, et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 2001;33:257-61.
49. Sharma P, Jaffe P, Bhattacharya A, et al. Fate of high-grade dysplasia at 1 year after endoscopic ablation with Nd:YAG laser and electrocautery. Am J Gastroenterol 2000;95:79-82.
50. Weston AP. The use of lasers in Barrett's esophagus. Gastrointest Endoscopy Clin N Am 2003;13:467-81.
51. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy of Barrett's oesophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003;58:193-8.
52. Gossner L, Stolte M, Stroke R, et al. Photodynamic therapy of high-grade dysplasia and early stage carcinomas by means of 5-aminolaevulinic acid. Gastroenterology 1998;114:447-55.
53. Gossner L, May A, Pech O, et al. Photodynamic therapy of Barrett's esopagus with dysplasia or early cancer. Gastroenterology 199, 116:G1811.
54. Javaid B, Watt P, Krasner N. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Laser Med Sci 2002;17:51-6.
55. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barrett's esophagus. Am J Surg Pathol 1998;22:239-45.
56. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo-controlled trial. Gut 2000;47:613-17.
57. Folk GW, Rice TW, Goldblum TR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastointest Endosc 1999;49:170-6.
58. Peters FTM, Ganesh S, Kuipers EJ, et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999;45:489-94.
59. Wang K, Norbash A, Geller A, et al. Endoscopic ultrasonography in the assessment of Barrett's esophagus with high grade dysplasia or carcinoma. Gastroenterology 1996;110:A611.
60. Scotiniotis IA, Kochman ML, Lewis JD, et al. Accuracy of endoscopic ultrasound in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 2001;54:689-96.
61. Canto MIF, Cruz-Correa MR, Heitmiller RF, et al. What is the accuracy of endoscopic ultrasound lymph node staging in patients with Barrett's esophagus and high grade dysplasia or early cancer? A prospective study with implications for endoscopic therapy. Gastrointest Endosc 2001;53:AB171.
62. Buttar N, Wang K, Lutzke L, et al. The use of endoscopic ultrasonography in Barrett's esophagus. Gastrointest Endosc 2001;53:AB172.
63. Wiersema MJ, Wiersema LM, Khusro Q, et al. Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions. Gastrointest Endosc 1994;40:199-206.
64. May A, Gossner L, Pech P, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-91.
65. Seewald S, Akaraviputh T, Seitz U, et al. Circumferential endoscopic mucosal resection and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854-9.
66. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998;123:432-9.
67. Inoue H, Takeshita K, Hori H, et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993;39:58-62.
68. Chaves DM, Sakai P, Mester M, et al. A new endoscopic technique for the resection of flat polypoid lesions. Gastrointest Endosc 1996,40:224-6.
69. Fleischer DE, Dawsey S, Tio TL, et al. Tissue band ligation followed by snare resection (band and snare): a new technique for tissue acquisition in the esophagus. Gastrointest Endosc 1996;44:68-72.
70. Toda M, Murakami A, Karita M, et al. Endoscopic resection of early gastric cancer. Endoscopy 1993;25:445-50.
71. Martin TR, Onstad GR, Silvis SE, et al. Lift and cut biopsy technique for submucosal sampling. Gastrointest Endosc 1976;23:29-30.
72. Radu A, Grosjean P, Fontolliet C, et al. Endoscopic mucosal resection in the esophagus with a new rigid device: an animal study. Endoscopy 2004;36:298-305.
73. Overholt BF, Lightdale CJ, Wang K, et al. International multicenter partially blinded randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 24 month follow-up. Gastroenterology 2003;124(suppl 1):151.
74. Kapoor N, Ragunath K, Raman VSVS, et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: long term results of a randomised prospective trial. Gut 2005;54(Suppl II):A33.
75. Hoge M, Sieresma PD, van Dekken H, et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 2004;53:785-90.
76. Kelty CJ, Ackroya R, Brown NJ, et al. Endoscopic ablation of Barrett's oesophagus: a randomised controlled trial of photodynamic therapy vs argon plasma coagulation. Aliment Pharmacol Ther 2004;20:1289-96.
77. Dulai G, Jensen DM, Cortina G. MPEC is superior to APC in sustained ablation of Barrett's. Gastroenterology 2004;126:A35.
78. Solaymani-Dodaran M, Logon RFA, West J, et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53:1070-4.
79. Kendall C, Stone N, Shepherd N, et al. Raman spectroscopy a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol 2003;200:602-9.
80. Noguchi H, Naomoto Y, Kondo H, et al. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg Lap Endoscopy Percut Tech 2000;10:343-50.
81. Ahmad NA, Kochman ML, Long WB, et al. Efficacy, safety and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002;55:390-6.
82. Takeshita K, Tani M, Inoue H, et al. Endoscopic treatment of early oesophageal or gastric cancer. Gut 1997;40:123-7.
83. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000;52:328-32.
84. Buttar NS, Wang KK, Lutzke LS, et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001;54:682-8.